Comparison of the Efficacy of Piperacillin/Tazobactam and Meropenem, with or without Intravenous Immunoglobulin, as Second-Line Therapy for Febrile Neutropenia: A Prospective, Randomized Study

• Autores principales: Hirozumi Sano (Autor), Ryoji Kobayashi (Autor), Satoru Matsushima (Autor), Daiki Hori (Autor), Masato Yanagi (Autor), Koya Kodama (Autor), Daisuke Suzuki (Autor), Kunihiko Kobayashi (Autor)
• Formato: Libro
• Publicado: The Korean Society of Pediatric Hematology-Oncology, 2021-10-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background : : Febrile neutropenia (FN) remains an important complication in pediatric cancer patients. The present study compared the efficacy of meropenem (MEPM) and piperacillin/tazobactam (PIPC/TAZ) with or without intravenous immunoglobulin (IVIG) as second-line therapy for FN in pediatric pati...